Psylink

We are developing a new class of targeted psychedelic agents to selectively intervene with serotonin receptors. Using synthetic biology, genome engineering tools we create well-known and new psychedelic derivatives used in preclinical and clinical research to eradicate most debilitating mental healt... Read more